$ETON Eton Pharmaceuticals, Inc. Insider Trading
Get free email notifications about insider trading in Eton Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Eton Pharmaceuticals, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Eton Pharmaceuticals, Inc. for free.
CIK Number: 0001710340
IRS Number: 371858472
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: ETON
Company Address: 21925 W. FIELD PARKWAY SUITE 235 DEER PARK 60010-7208
Phone number: 847-616-5734
Eton Pharmaceuticals, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 27 2021 | ETON | Eton Pharmaceutica ... | Opaleye Management Inc. | 10% Owner | Sell | S | 8.49 | 4,600 | 39,054 | 145,600 | 150.2 K to 145.6 K (-3.06 %) |
May 27 2021 | ETON | Eton Pharmaceutica ... | Opaleye Management Inc. | 10% Owner | Sell | S | 8.49 | 121,400 | 1,030,686 | 3,652,100 | 3.8 M to 3.7 M (-3.22 %) |
May 27 2021 | ETON | Eton Pharmaceutica ... | Opaleye Management Inc. | 10% Owner | Sell | S | 8.57 | 2,800 | 23,996 | 150,200 | 153 K to 150.2 K (-1.83 %) |
May 27 2021 | ETON | Eton Pharmaceutica ... | Opaleye Management Inc. | 10% Owner | Sell | S | 8.57 | 65,500 | 561,335 | 3,773,500 | 3.8 M to 3.8 M (-1.71 %) |
May 27 2021 | ETON | Eton Pharmaceutica ... | Opaleye Management Inc. | 10% Owner | Sell | S | 8.53 | 2,000 | 17,060 | 153,000 | 155 K to 153 K (-1.29 %) |
May 27 2021 | ETON | Eton Pharmaceutica ... | Opaleye Management Inc. | 10% Owner | Sell | S | 8.53 | 46,000 | 392,380 | 3,839,000 | 3.9 M to 3.8 M (-1.18 %) |
Apr 12 2021 | ETON | Eton Pharmaceutica ... | HARROW HEALTH, INC. | 10% Owner | Sell | S | 7.00 | 1,518,000 | 10,626,000 | 1,982,000 | 3.5 M to 2 M (-43.37 %) |
Oct 16 2020 | ETON | Eton Pharmaceutica ... | Opaleye Management Inc. | 10% Owner | Buy | P | 7.00 | 15,000 | 105,000 | 155,000 | 140 K to 155 K (+10.71 %) |
Oct 16 2020 | ETON | Eton Pharmaceutica ... | Opaleye Management Inc. | 10% Owner | Buy | P | 7.00 | 15,000 | 105,000 | 155,000 | 140 K to 155 K (+10.71 %) |
Oct 16 2020 | ETON | Eton Pharmaceutica ... | Opaleye Management Inc. | 10% Owner | Buy | P | 7.00 | 385,000 | 2,695,000 | 3,885,000 | 3.5 M to 3.9 M (+11.00 %) |
Oct 16 2020 | ETON | Eton Pharmaceutica ... | Opaleye Management Inc. | 10% Owner | Buy | P | 7.00 | 385,000 | 2,695,000 | 3,885,000 | 3.5 M to 3.9 M (+11.00 %) |
Mar 16 2020 | ETON | Eton Pharmaceutica ... | BAUM MARK L | Director | Option Exercise | A | 3.58 | 27,400 | 98,092 | 27,400 | |
Mar 16 2020 | ETON | Eton Pharmaceutica ... | Troutman William Wilson | CFO, Treasurer & Se ... | Option Exercise | A | 3.58 | 186,200 | 666,596 | 186,200 | |
Mar 16 2020 | ETON | Eton Pharmaceutica ... | CASAMENTO CHARLES J | Director | Option Exercise | A | 3.58 | 27,400 | 98,092 | 27,400 | |
Mar 16 2020 | ETON | Eton Pharmaceutica ... | MAIER PAUL V | Director | Option Exercise | A | 3.58 | 27,400 | 98,092 | 27,400 |